Cupric chloride (II) chelate compounds by using 1-pyridyl-beta-carboline as ligand, and synthesis method and application thereof
A synthetic method and compound technology, applied in the field of medicine, can solve the problems of production cost limitation, drug resistance and side effects, in-depth research, etc., and achieve good medicinal value and strong anti-tumor activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Embodiment 1: the compound shown in formula (II) is the synthesis of 1-pyridine-beta-carboline (KL)
[0047] 1) Dissolve 1.60g (10mmol) of tryptamine in 70mL of dichloromethane, then add 1.07g (10mmol) of pyridine-2-carbaldehyde, and heat to reflux for 8 hours; after the reaction, distill under reduced pressure to obtain the crude compound 1 ;
[0048] 2) Dissolve 2.49g (10mmol) of compound 1 in 80mL of glacial acetic acid, then add 13.4g of manganese acetate hydrate (Mn(Ac) 3 ·nH 2 (0), heated to 80°C, reacted overnight, evaporated the solvent, added 100mL water, extracted 3 times with ethyl acetate, combined the organic phases, evaporated the solvent to obtain an oily crude product, and then purified by flash liquid chromatography (V 石油醚 :V 二氯甲烷 =1:1), to obtain light yellow crystal compound 2 (yield about 73%).
[0049] The resulting pale yellow crystals were subjected to proton nuclear magnetic resonance spectrum, carbon nuclear magnetic resonance spectrum, elec...
Embodiment 2
[0057] Embodiment 2: the synthesis of ligand KL
[0058] 1) Dissolve 1.60 g (10 mmol) of tryptamine in 70 mL of toluene, then add 1.07 g (10 mmol) of pyridine-2-carbaldehyde, and heat to reflux for 6 hours. After the reaction, distill under reduced pressure to obtain the crude compound 1;
[0059] 2) Dissolve 2.49g (10mmol) of compound 1 in 80mL of glacial acetic acid, then add 13.4g of manganese acetate hydrate (Mn(Ac) 3 ·nH 2 (0), heated to 70°C, reacted overnight, evaporated the solvent, added 100mL water, extracted 3 times with ethyl acetate, combined the organic phases, evaporated the solvent to obtain an oily crude product, and then purified by flash liquid chromatography (V 石油醚 :V 二氯甲烷 =2:3), to obtain light yellow crystal compound 2 (the yield is about 55%).
[0060] The obtained pale yellow crystals were analyzed by H NMR, C NMR, electrospray mass spectrometry and single crystal diffraction, and it was determined to be the target product 1-pyridine-β-carboline.
Embodiment 3
[0061] Embodiment 3: the synthesis of ligand KL
[0062] 1) 1.60g (10mmol) tryptamine is dissolved in the mixed solvent that is made up of the methanol of 30mL and the ethanol of 40mL, then add 1.07g (10mmol) pyridine-2-carboxaldehyde, heat to reflux for 12 hours, after the reaction finishes, reduce Press distillation to obtain crude product compound 1;
[0063] 2) Dissolve 2.49g (10mmol) of compound 1 in 80mL of glacial acetic acid, then add 20mmol of Pb(Ac) 4 , heated to 90°C, reacted overnight, evaporated the solvent, added 100mL of water, extracted 3 times with ethyl acetate, combined the organic phases, evaporated the solvent to obtain an oily crude product, and then purified by flash liquid chromatography (V 石油醚 :V 二氯甲烷 =3:2), the light yellow crystal compound 2 was obtained (the yield was about 67%).
[0064] The obtained pale yellow crystals were analyzed by H NMR, C NMR, electrospray mass spectrometry and single crystal diffraction, and it was determined to be the ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com